prevention of utis in endourological surgery: regulation, guideline, evidence, and practice in...
TRANSCRIPT
Prevention Of UTIs in Endourological Surgery: Regulation, Guideline, Evidence, and Practice
In Taiwan
Stephen SD Yang, M.D., PhD. Associate Professor of Department of Urology,
Tzu Chi Uninersity, Hualien, TaiwanChief of Department of Surgery
Tzu Chi General Hospital, Taipei Branch,Taipei, Taiwan
楊緒棣 副教授,外科部 主任慈濟綜合醫院台北分院
2007/06/09
Fight for Antibiotic
Abuse!
• In 1990s,• 30% of URI cases used
antibiotics • 6 days for SSI prophylaxis
In 2004 17% of URI cases used antibiotics.3 days for SSI prophylaxisLess use of 2nd line antibiotics
1990 Active Surveillance
1995 NHI: strict regulations
2000 Control Yuan Involvement
2001 National Surveillance Program
2002 Public educationSchool Education (junior high school)
2003 Hospital Evaluation
張上淳 感控雜誌 200616:205-18
TQIP 1999 Surveillance for SSI
2002 TMAC Medical students
Another field is animal use of antibiotics
Use and Abuse of Surgical Antibiotic Prophylaxis in Hospitals in Taiwan
• Sep 1998 –March 1999, 629 patients in 14 hospitals.
• 499 (79%) for surgical prophylaxis (not including GU) . 89% clean wound.
• Mean no. of antibiotics: 2 kinds.• 1st Cepha 449 (90%) and Aminoglycosides 2
33 (50%)• Mean duration of use: 6 days. • More than 70 % use longer than 3 days. • Mc Donald LC, et al: J Formos Med Assoc 20
01;100:5-13.
Bacterial Infection: War Between Host and Bacteria
HostDefense
BacterialVirulence
UrologicalInterventio
n
decrease increase
Abuse of Antibiotics
Impaired Immune system, or anatomical factors
Materials and Methods• Regulations: the publications of the National Health In
surance Bureau, Taiwan. The Payer of medical fee. The Boss!!
• Guidelines: (1) Taiwanese Association of Infectious Disease. (2) EAU UTI guideline 2006. (3) Campbell-Walsh Urology 9th edition, 2007. The academic consensus?
• Evidences: Published reports from Taiwan and around the world. Retrospective or prospective data from TCH, Taipei, Taiwan
• Practice: Email survey to 69 (17.3%) of 400 Urologists in Taiwan.
• The prescribers. The possible benefits/risks takers.
Practice of Urologists in Taiwan Practice of Urologists in Taiwan N = 69
Years of practice
Age distributionWorkplace distribution
Grades of academic position
Regulations (I) of Perioperative Antibiotics in Surgery: Taiwan Health Insurance Bureau
• 4. Price of the agents should be considered.
• 5. First line antibiotics should be used first. (table)
• 6. The following conditions may use second line antibiotics: (3) Confirmed by infection men, (4) Apparent surgical infections.
• Chap. 10. Antimicrobial agents. Pp 58-65. Regulations of the payment for pharmaceutical agents. Central Health Insurance Bureau. 2006/07. (WWW.nhi.gov.tw)
Regulations (II) of Perioperative Antibiotics in Surgery: Taiwan Health Insurance Bureau
• 7. Conditions to use second line antibiotics: (1) Culture proved that second line antibiotics is required in cases of using 1st line antibiotics longer than 72 hours. (2) 7 days later after using first line antibiotics for 72 hours and still not effective after changing to another first line antibiotics.
Regulations (III) of Perioperative Antibiotics in Surgery: Taiwan Health Insurance Bureau
• 8. Prophylatic antibiotics for surgery.• (1) Clean wound: -A) clean wound such as her
niorraphy, thyroidectomy: no antibiotics, or at most one dose before op.
• (2) Clean contaminated wound: GU, GI, Chest, Gyn, etc. First line medicine for 24 hours. Specify indication of using antibiotics longer than 48 hours or second line ABx.
List of First Line Antibiotics Allowed in Taiwan
• Oral: amoxicillin, Cefalexin, Clindamycin, doxycyclin, minocycline, nalidixic acid, nitrofurantoin, trimethoprime/ sulf methoxazole, etc.
• Parental: Cefazoline, cephalothin, gentamicin, penicillin, etc.
• Table 1. p75. List of first line antibiotics. Central Health Insurance Bureau. 2006/07. (WWW.nhi.gov.tw)
• BREAKING THE RULES, GETTING NO PAY AND PENALTY!!!
Guidelines for the use of prophylatic antibiotics in urological surgery in Taiwan (only 3 procedures)
Site/procedure
Likely pathogens
Recommended antibiotics
Alternative Duration
TRUSP-Bx
Enteric GNB
Cefazoline 1gm IV at IA
GM 2mg/kg IV on call to OR
or Ciproxacin 500mg oral or 400mg IV on call to OR
1 dose
TU-P-Bx Enteric GNB
Cefazoline 1gm IV at IA
GM 2mg/kg IV on call to OR
or Ciproxacin 500mg oral or 400mg IV on call to OR
1 dose
TUR-BT Enteric GNB
Cefazoline 1gm IV at IA
GM 2mg/kg IV on call to OR
1 dose
Microbiol Immunol Infect 2004;37:71-4Microbiol Immunol Infect 2004;37:71-4
Guideline for Prophylaxis for Cystoscopy
• EAU 2006: no prophylaxis. (2nd gen Cephalosporines or TMP +/- SMX for patients at risk of UTI).
• Campbell-Walsh 2007: No absolute indication for antimicromial prophylaxis for cystoscopy, but indicated in patients at risk of UTI.
Prophylaxis for CystoscopyProphylaxis for CystoscopyRegulations: 0-1 dose 1st line antibotics?Regulations: 0-1 dose 1st line antibotics?
Prophylaxis for UTI after single catheterization or cystoscopy
• The risk of infection after one time catheterization in healthy woman: 1-2%.
• Of patients with sterile urine, 2.2% -7.8% reported culture-proven UTIs. While Rane, et al, (2001) reported a high rate of 21% after cystoscopy.
• Single dose prophylaxis reduced infections to 1% to 5%. No significant systemic infection.– Campbell –Walsh Urology, 2007, 9th ed.
UTI after Urodynamics and/or cystoscopy
• After UDS, 19 (20%) of 97 pt with negative culture developed a positive culture afterward. No significant risk factor was detected Okorocha I, et al: BJU International 2002;89:863-7
• Two doses nitrofurantoin (n=74) vs. placebo (n=68) for women undergoing combined urodynamics and cystourethroscopy: No difference in rate of post exam UTI . Cundiff GW, et al: Obstet Gynecol 1999;93(5 pt 1):749-52.
• One dose 400mg Norfloxacin: no significant effect in cases received flexible cystoscopy. Wilson L, et al: J Endourol 2005;19:1006-8.
Temporary Data for Single dose Cephalexin prophylaxis for Cystoscopy
• Up to Apr. 30, 2007• Placebo: 9 (M7, F2), one female with carruncl
e had post exam UTI.• Cephalexin : 7 (6M, 1F). Nil had UTI.• Temporary conclusion: no prophylaxis is req
uired in case with no risk factor, e.g. Bladder outlet obstruction.
Conclusions on prophylactic antibiotics for cystoscopy
• UTI after UDS or cystoscopic examinations varied from 2% to 21%.
• Symptoms of UTI after cystoscopy were usually not severe, and spontaneous resolution of UTI occurred.
• Pre-instrumentation prophylactic antibiotics may be not necessary.
• Postmenopausal women and all men undergoing cystoscopy may need prophylaxis.
Prophylaxis for Shock Wave Lithotripsy (SWL) Regulations : 0-1 dose 1st line antibotics?
• EAU guideline: no prophylaxis for SWL• Campbell-Wash: prophylaxis! (In patients
with stone and sterile urine, infection rate after SWL reduced from 5.7% to 2.1%, Pearle 1997)
• A history of a recent UTI or of infectious stones should warrant a full treatment course of antimicrobial agents before SWL.
Prophylaxis for SWL: a meta-analysis
• 8RCT, 885 patients.
• The incidence of UTIs after SWL without prophylaxis: 0%-28%., with a median of 5.7%.
• Prophylactic antibiotics in cases with sterile urine decrease UTIs: 0-7.7%, with a median of 2.1%. (Pearle MS and Roehrborn CG, Urology 1997; 49:679-86)
Discussion: Prophylactic Antibiotics in SWL without UTIs
• 91% did not use preop ABx. 65% did not use post op. ABx.
• 23% use post op. ABx for >1 days.! But preoperative oral antibiotics is more im
portant and postop antibiotics may be not necessary in cases without postop fever!
• Stone size and location may have an impact on post SWL infection rate. Further study is required.
• Our impression: stone less than 10mm may not need prophylaxis.
• Recent pain attack and no fever no prophylaxis?
Prophylaxis for Ureteroscopoic lithotripsy (USL)Regulations: Clean contaminated wound. First li
ne medicine for 24 hours. • EAU 2006: uncomplicated distal ureteral ston
e no prophylaxis. Proximal or impacted stone, or PCNL
all patients need prophlaxis with 2nd or 3rd cepha or TMP +/- SMX or Aminopenicillin/BLI or fluoroquinolones. Short course (1-3days) is recommended.
• Campbell-Walsh 2007: recommended prophylaxis.
Prophylaxis for USL• Incidence of UTI after USL is 1.3% in a large se
ries. (Sosa RE, 159-68.)• Knopf et al, 2003: RCT to prove that prophylac
tic fluoroquinolone administration significantly reduced postop UTIs in a healthy population (n=113) with ureteral stone and uninfected preop urine (12.5% 1.8%). (F-Q not allowed in Tw)
• Taylor AL, et al, 2002: 63 URS in 56 cases, including URSL in 54 sides. Perioperative use of antibiotics: 3 (7%) UTIs (pyrexia, PN, pyonephrosis). recommend perioperative antibiotics. (BJU International 89:181-5)
Antimicrobial prophylaxis for URSL in TCH, Taipei: A Retrospective Study
• Between Sep. 2006 and Apr. 2007, 168 patients underwent URSL. Of them 127 had single ureteral stone.
• Preoperative no signs of UTI in 62 patients (Prophylaxis Group), 57 patients had signs of UTI (Therapeutic groups), and 8 patients did not check urinalysis.
• Preop urine culture: 0/2 positive in the prophylaxis group ; 7/10 (70%) positive in the therapeutic group (2 E coli, 2 P mirabilis, 2 mixed growth, 1 Group B streptoccous
• Cefazoline 1.0 gm IV at induction was used preoperatively in all. 10% add GM.
• DJ was inserted as the clinician’s decision.
Stone Size and Postoperative Infection
Size (mm)
N Post Pyuria Back to ER
+ - ? Pain UTI* Others
>10 25 7 (44%) 9 9 0 0 1
5-10 44 11 (52%) 10 23 3 1 (2.3%)
1
<5 58 17 (50%) 17 24 2 3 (5.2%)
0
Total 127 35 (49%) 36 56 5 (3.9%)
4 (3.1%)
2
(1.6%)* Febrile UTI
Stone fragmentation rate: 99.2%.Stone fragmentation rate: 99.2%. ER rate: 8.6%
Antimicrobial prophylaxis for USL in TCH, Taipei: Stone Size
Groups Antibiotics N Mean stone size (mm)
Stone location
Up Mid Low
Prophylactic Post Op ABx (-) 32 6.7 ± 4.4 14 8 10
Post Op ABx (+) 26 6.2 ± 5.3 9 2 13
Subtotal 58 6.5 ± 4.7 23 10 23
Therapeutic Post Op ABx (-) 7 11.2 ± 5.1 2 4 1
Post Op ABx (+) 39 7.4 ± 5.5 16 9 14
subtotal 46 8.0 ± 5.4 18 13 15
Total 104 7.2 ± 5.0 41 23 38
* Patients without preoperative antibiotics were excluded.
Antimicrobial prophylaxis for URSL in TCH, Taipei: Prophylactic Group
N Post op Pyuria Back to ER
Positive Negative NA UTI Pain *
Post Op ABx (+)
26 6 (37.5%) 10 10 1 3
Post Op ABx (-)
32 7 (64%) 4 21 1 1
DJ (+) 46 11 (85%) 2 26 2 (4%)
3
(6.5%)
DJ (-) 10 2 (40%) 3 5 0 1
DJ + in 22/26 of post anti + in 24/32 of post anti -
Post op use of antibiotics tended to reduce pyuria rate (p=0.18), but not febrile UTI rate.
Antimicrobial prophylaxis for URSL in TCH, Taipei: Therapeutic Group
N Post op Pyuria Back to ER
Positive Negative NA UTI Pain *
Post Op ABx (+)
39 13 (54%) 11 15 1 (2.6%)
1
Post Op ABx (-)
7 0 5 2 0 0
DJ (+) 39 13 (52%) 12 14 1 (2.6%)
1
DJ (-) 7 0 4 3 0 0
DJ + in x/39 of post anti + in y/7 of post anti -
Post op use of antibiotics did not reduce pyuria rate, nor febrile UTI rate.
Postoperative Use of Antibiotics Did not Reduce Pyuria
post op Antibiotics
Pyuria* Febrile UTI
Pain
Yes 19/40 (47.5%)
2/65 (3.1%)
4/65 (6.2%)
Nil 7/16
(43.8%)
1/39 (2.6%)
1/39 (2.6%)
* P=0.80
DJ insertion: a strong impact on postoperative outcome
Pyuria* Febrile UTI
Pain
DJ Positive
24/38 (63%)
3/85 (3.5%)
4/85 (4.7%)
DJ negative
2/9
(22%)
0 1/17 (5.9%)
* P=0.026 <0.05
Discussion : Antimicrobial prophylaxis for URSL in TCH, Taipei
• Preoperative pyuria usually meant bacteriuria. (70% + predictive rate).
• Totally, febrile UTI occurred in 4/127 (3.1%) and All the 4 patients with UTI had DJ inserted.
• Stone size does not matter!!• Postop antibiotics were used more frequently i
n patients with preop pyuria, while it was resulted in no gain.
• DJ insertion had a strong impact on postop. Pyuria (63%), and febrile UTI (3.5%).
Discussion: Practice of Prophylactic Antibiotics in USL without signs of UTI
• 26% did not use pre-op antibiotics. (Not complying to the rules!)
• 23% did not use post op antibiotics. Follow our results.
• 10% use two kinds of antibiotics. (Break the rule!)
• 23% use postop. antibiotics for 3 days. (Break the rule!)
USL USL (B) With pyuia, (B) With pyuia, no fever, no APNno fever, no APN
Antibiotic
N=42
Antibiotic dose
Discussion: Practice of Prophylactic Antibiotics in USL in patients with pyuria, without fever
• Almost all (94%) use pre-op antibiotics.
• 23% did not use post op antibiotics. Follow our results.
• 33% use two kinds of antibiotics. (Adequate?)
• 40% use postop. antibiotics 3 days. ≧(Break the rule!)
• Afraid of infection without evidence?
Discussion: Practice of Prophylactic Antibiotics in USL in Patients Without fever
• USL is frequently associated with pyuria (around 50%), febrile UTI (3.1%) and possible ureteral stricture.
• Recommend prophylaxis for all patients. • Optimal dose: 1 dose for cases with single ur
eteral stone without postoperative fever.• Preoperatvie pyuria did not need additional a
ntibiotics.
Prophylaxis for PCNL Regulations : short course, 1-3 days?
• EAU guideline:2nd or 3rd cepha or TMP +/- SMX or Aminopenicillin/BLI or fluoroquinolones. Short course (<72 hrs.)
• Campbell 2007: Ampicillin + GM or Fluoroquinolones. Single dose to 1 day.
Antibiotic prophylaxis in PCNL: prospective study
• 81 patients with preop sterile urine.• 43 cases with single dose (ofloxacin 200mg iv) vs. 38
cases with standard tx (ofloxacin 400mg iv per day) till catheter removal.
• 19 (23%)patients had positive stone culture. • Post fever: 9/43 (21%) and 8/38 (21%). • The febrile patients had longer operations with the us
e of more irrigation fluid and longer postoperative hospital stays.
• Short-term prophylaxis has no advantage over single-dose prophylaxis.
• Dogan HS, et al. J Enodourol 2002;16:649-53.
Discussion on Prophylactic Antibiotics in PCNL without signs of preoperative infection
• 81% use pre-op antibiotics, and of them 41% use combination therapy.
• 79% use short course (1-3 days) post op antibiotics.
• Few cases of staghorn stone had sterile urine.
• Renal function impairment is common in these cases.
• More studies are needed to confirm the adequacy of single dose prophylaxis.
Prophylaxis for TURP
Regulations : short course, 1-3 days?.
• EAU guideline: all patients.
• Campbell: all patients till catheter removal.
• Taiwan guideline for TUR BT: cefazoline 1.0 gm IV at induction.
Antimicrobial Prophylaxis for TURP
• A meta analysis of 32 RCT showed that a risk reduction in bacteriuria from 26% to 9%. Septicemia from 4.4% to 0.9%.
• FluoroQ, aminoglycosides, TMP/SMX , Cephalosporines. Used for a short course (2-5 days), or while catheter remained in place.
• Failure to eradicate bacteriuria resulted in bactereuria in 50% of patients (Morris 1976).
Discussion on Prophylactic Antibiotics in TURP
• 16% did not use AMP: no complying to guidelines.
• 17%-26% use combination therapy: abuse?
• 14% use antibiotics longer than 3 days: break the rule?
Infection: War Between Host and Bacteria
HostDefense Bacterial
Virulence
UrologicalIntervention
decrease increase
Abuse of Antibiotics
Impaired Immune system, or anatomaica factors Dirty instrument
Proper AMP
Proper Disinfection
SSI in the Elderly Population• Kaye KS, et al: CID 2004;39:1835-41. A review.• THE RISK OF SSI DOES NOT SEEM TO INCREASE
AFTER THE AGE OF 65 YEARS. • More co-morbidity in the elder patients. • Independent risk factors of SSI: obesity, COPD,
contaminated or dirty wound. • Protective factor: private insurance. (MONEY
MATTERS)• Sharing the same clinical presentation of infection
and the pathogens that cause infection.• However, the mortality rate, the duration of
hospitalization, and the costs associated with hospital care are greater for elderly patients with SSI than for younger patients with SSI.
The Host:
Obese Patients Run Higher Risk of
Postoperative Complications • Bamgbade OA, et al: World J Surg 2007 (3)
• Analyze 6773 patients. 2217 were obese, including 993 morbid obesity.
• Heart attack rate 0.5% vs. 0.1%. • Wound infection 6% vs. 3.5%.• Peripheral nerve injury 0.4% vs. 0.15. • UTI 3.9% vs. 2.6%.• Death rate: 2.2% vs. 1.2%.• Suggestions: Morbid obesity patient have out
patient surgery should undergo a 23-hour hospital stay for post-op monitoring.
‘Complicated' UTIs: They are not standard patients!
• Foreign bodies in the urinary tract, such as indwelling urinary catheters and stents;
• Increased postvoiding residual urine >=100 mL • urinary tract stones • congenital developmental or anatomic anomalies; • obstructive uropathy (eg, as a result of stones, fibrosis, or
bladder outlet obstruction); • vesicoureteric reflux, or structural urologic abnormalities,
including surgically created structural changes, such as ileal loops;
• neurogenic bladder disorder (with residual urine and/or overactive detrusor)
• uremia from renal causes; and • renal transplantation.
General measures recommended for prevention of surgical infections
• Bathing patients preoperatively with an antimicrobial soap has been suggested as a preventive strategy. Proper vaginal disinfection.
• Preoperative removal of hair from the operative site by clipping rather than by shaving, reduces the overall incidence of SSI and should minimize the risk of S. aureus infection.
• Adequate Scrubbing of surgeons’ and all assistants’ hands before the procedure.
Proper Disinfection
Inappropriate Disinfection of Endoscope
• Painful experiences in TCH, Taipei, Taiwan.
• Cluster infection in patients after prostate biopsy in 2005.
• Cluster infections in patients after USL in 2006.
• All were pseudomonas infection.• Reluctant to report! A war between
Urologists and OR nurses? A punishment form superior?
Susceptibility of Isolates in TCH, Taipei
Ampicillin
Amox+clavu
Cefazoline
Gentamicin
Ciproxin
Levofloxacin
Ceftriaxone
Vancomycin
E- Coli 25 44 75 73 70 75 87 -
P-aeruginosa
- - - 83 76 73 - -
K- pneumoniae
0 78 82 81 86 86 88 -
S aureus
- - - 55 59 66 - 100
E faecalis
96 - - - - - - 100
Timing of Antibiotics
• Parental agents: 30-60 minutes IV at induction of anesthesia.
• Oral agents: 2 hours before operation.
• Additional dose in prolonged operation. E.g. >3-4 hours.
Proper AMP
Monotherapy Versus Combination Therapy
• Most UTIs can be treated with monotherapy.• Some complicated infections, especially CAUTI,
may have a polymicrobial etiology, in which case multiple antibiotics may be needed. Combination therapy is often used (eg, ampicillin is often combined with gentamicin), but there is little evidence that such combination therapy is more effective than monotherapy in most cases.
• Note: Taiwanese doctors tend to combine cefalosporines with aminoglycosides.
Oral Versus Intravenous Administration
• Most uncomplicated UTIs, and many complicated infections can be treated adequately with oral therapy. (Equally effective?!!)
• Generally, intravenous therapy would be indicated in seriously ill patients with complicated UTIs; and patients with pyelonephritis at risk.
Surgery and Cephalosporines:
A Marriage Made In Heaven Or Time For Divorce • Morgan M. Internet J Surg. 2006; 8(1)
• Cephalosporines are ineffective against the common pathogens causing SSI and are associated with superinfection.
• In UK, 47% of microorganism identified as causing SSIs were staphylococci, of which 82% were Staph aureus. 62% Staph aureus were MRSA.
• Enterococcal infections (predominantly UTI and enodcarditis) are on the increase, and this may well be due to overuse of the cephalosporines.
Proactive Monitoring to Decrease SSI • Dellinger EP, et al. Am J Surg 2005;190:9-15.• 56 hosptials and 42 quality-improvement organization
s form 50 states or territories in the USA agreed to participate.
• Administration of the prophylactic antibiotic prior to incision increased from 72% to 92%.
• Antibiotic prophylaxis was discontinued within 24 h increased from 67% to 85%.
• The overall SSI decreased from 2.28% in the first 3 months of the study to 1.65% in the last 3 months.
• Examine our results and Change our practice.
• May we all have reduced SSI in enodurological surgeries!
Gaps Between Practice and Regulations/Guidelines (I)
• Controversy exists between different guidelines.
• The guidelines were conducted by experts and based on published results that may be the best clinical results, and that may be not true for average doctors.
• Regulations were made for financial causes rather than scientific evidence.
• Regulations/Guidelines may be out of date.
• Urologists were not involved in making up the Guidelines.
Gaps Between Practice and Regulations/Guidelines (II)
• Details or variations of each procedure were not discussed yet!
• Invasiveness of the procedure was less discussed in the guidelines.
• Serious infection did occur! (Strong and permanent memory to use more antibiotics).
Gaps Between Practice and Regulations/Guidelines (III)
• High Drug resistance in local community. • Surgeons Do not trust the disinfection proce
dures. Too many points to miss! • Surgeons’ heavy duty to kill any pathogens e
ntering the patients. Safety for the patients? • Afraid of law suing? Safety for the doctors: o
veruse of antibiotics to prevent minor infections.
07:00-08:30
08:30-09:15
09:15-10:00
10:00-10:30
10:30-12:00
12:00-13:30
13:30-14:30
14:30-15:00
15:00-15:30
15:30-17:00
17:30-18:00
18:00-19:00
19:00-19:30
19:30-21:00
Poster Session Poster Session
4th AnnualMeeting ofGCAMID
Break
Plenary 5-8
Satellite Symposium& Lunch
1-2
Break
Symposium 5-8
Poster Session
Farewell Party
SatelliteSymposium
11-12
Plenary 21-24
Break
City Tour
Symposium 13-16 Symposium 21-24
Plenary 13-16
Break
SatelliteSymposiu
m & Dinner7-8
GCAMIDForum
GCAMIDGala
DinnerWelcomeReception
Registration(08:30-18:00)
OpeningCeremony &Keynote 1
Satellite Symposium3-4
Congress Banquet
Satellite Symposium& Lunch
5-6
SatelliteSymposium &
Lunch9-10
12:00-12:30Closing
Ceremony
Symposium 1-4 Symposium 9-12 Symposium 17-20Symposium 25-
28
Break Break Break
Plenary 1-4 Plenary 9-12 Plenary 17-20 Plenary 25-28
Wed. Dec.3
Meet the Experts Meet the Experts
Keynote 2 Keynote 3 Keynote 4 Keynote 5
Sat. Nov.29 Sun. Nov.30 Tue. Dec.2Mon. Dec.1
Welcome to Taipei, Taiwan 11th WPCCID and 5th AAUS!
November 29 ~ December 03, 2008
歡迎蒞臨台
北 E-mail: [email protected] for Abstract Submission: June 30, 2008
First200811th WPCC D 200811th WPCC D11th Western Pacific Congress on Chemotherapy and Infectious DiseasesNovember 29 - December 03, 2008Taipei International Convention Center, TaiwanFormosa ~ the Beautiful Island AnnouncementTaiwan's total land area is about 36,000 square kilometers; it is shaped like a tobacco leaf,that is narrow at both ends. Taiwan lies on the western edge of Pacific "rim of fire", andcontinuous tectonic movements have create majestic landforms and wonders. Taiwan seesclimates of many types: tropical, subtropical, and temperate, providing clear differentiationbetween the different seasons.The government has established 6 national parks and 11 national scenic areas to preserveTaiwan's best natural ecological environment and cultural sites. Take in the splendor andsheer heights of the cliffs at Taroko Gorge; take a ride on the Alishan train and experience itsbreathtaking sunset and sea of clouds. You can also soak up the sun in Kending, Asia'sversion of Hawaii; stand at the edge of Sun Moon Lake; traipse through the East Rift Valley;or visit the offshore islands of Kinmen and Penghu. It's fun in capital letters as well as anawesome journey of natural discovery!Taiwan's cultural aspects are not to be missed. The blending of Hakka, Taiwanese, andmainland Chinese cultures has produced a rich plethora of cultural and social color. Whetherit is religion, architecture, language, living habits, or food, it's just one big exciting melting pot!Food is the best representative of this cultural mix and match. Aside from cuisines fromdifferent parts of the mainland, you can also find the local Taiwanese cuisine and a variety offood from around the world. So for those of you who are international gourmet lovers, Taiwanis definitely the place to visit.Host OrganizationsInfectious Diseases Society of TaiwanTaiwan Society of MicrobiologyNosocomial Infection Control Society of TaiwanCollaborating OrganizationsInternational Society of Chemotherapy (ISC)Western Pacific Society of Chemotherapy (WPSC)Asian Association of UTI and STD (AAUS)in conjunction with 5th Asian UTI/STD Forum (AAUS 2008)Ms. Emily ShihAddress: 10F-2, No. 51, Sungjiung Road, 104 Taipei, TaiwanTel: +886-2-2504-4338 ext.18 Fax: +886-2-2504-4362E-mail: [email protected] DatesDeadline for Abstract Submission: June 30, 2008Deadline for Early Bird Registration: August 31, 2008Deadline for Pre-Registration: September 15, 2008Congress Dates: November 29 ~ December 03, 2008Congress Secretariat
Antimicrobial Prophylaxis for Clean Wound Surgery: Kaoshiung VGH
• In 1999~2000, 3110 surgical cases.• 156 (2%) cases did not use antibiotics at all.• Mean antibiotic days: 6.39 days (parental 2.41days a
nd oral 4.02 days).• SSI rate in clean surgery: one dose of AMP: 0.9%, on
e dose after surgery: 3.2%, no use : 1.9%.• 90% use 1st Cepha as AMP, and 50% aminoglycosid
es.
• Conclusion: one dose of AMP is enough and better than no use of AMP.
• Ho M: My route to education and medicine. 2002.
Back to ER rate
N ER
UTI Pain
Prophylactic Group
62 2 (3.2%) 4 (6.4%)
Therapeutic Group
57 1 (1.8%) 1 (1.8%)
No Preop data
8 1 (12.5%) 2 (25%)
Correctable Urologic Abnormalities That Cause
Bacterial Persistence Infection stones • Infection stones • Chronic bacterial prostatitis • Unilateral infected atrophic kidneys • Ureteral duplication and ectopic ureters • Foreign bodies • Urethral diverticula and infected periurethral glands • Unilateral medullary sponge kidneys • Nonrefluxing, normal-appearing, infected ureteral stumps
after nephrectomy • Infected urachal cysts • Infected communicating cysts of the renal calyces • Papillary necrosis • Perivesical abscess with fistula to bladder
Guidelines for the use of prophylatctic antibiotics in surgery in Taiwan
J J Microbiol Immunol Infect 2004;37:71-4Microbiol Immunol Infect 2004;37:71-4
Site/procedure
Likely pathogens
Recommended antibiotics
Alternative Duration
Herniorraphy + mesh, open or LPS
S. aureus
CoNS
Cephazolin 1gm, IV at IA
Clindamycin 600mg IV at IA
1 dose
Herniorraphy No mesh, open or LPS
S. aureus
CoNS
Nil or Cephazolin 1gm, IV at IA
Clindamycin 600mg IV at IA
1 dose
Colorectal ( clean contaminated)
Enteric GNB
Anaerobes
Oral Neomcin 1gm QID+ metronidazole 1gm qid the day before op or cefa+/- GM +/- metron IV at IA
Clindamycin +GM IV at IA. Or … or …
<1 day
Guidelines for Antimicrobial Therapy of UTIs in Taiwan
• J Microbiol Immunol Infect 2000;33:271-2.
Diagnosis Drug of Choice Alternative Choice
Asymptomatic bacteriuria or Acute bacterial cystitis
Nitrofurantoin,
1st or 2nd cepha,
TMP+SMX
Quinolones (pimpemic acid, etc)
NO FLUOROQUINOLONES
Ampicillin or amoxicillin
Ampicillin/sulbactam
Amoxicillin/calvulanate
Acute uncomplicated Pyelonephritis
TMP+SMX
1st or 2nd cephalo
Aminoglycosides
NO FLUOROQUINOLONES
Ampicillin or amoxicillin
Ampicillin/sulbactam
Amoxicillin/calvulanate
Aminoglycosides (single) + 1st or 2nd cepha,
Discussion: Prophylactic Antibiotics in TURP
• 16% did not use AMP (Did not comply to guidelines)
• 14% use postop ABx longer than 3 days. (Break the rule!)
• More use of combination antibiotics (preop. 17%, and postop.26%). (Cefazoline plus Gentamycin).
Prophylaxis for Nephrectomy Regulations for : 0-1 dose 1st line antibotics?
• EAU guideline:
• Campbell-Walsh 2007:
• Taiwan: single dose or short course, 1-3 days?. Clean wound after op for RCC. Clean contaminated wound after op for TCC.
Open or Laparoscopic Nephrectomy/Nephrourerectomy
• In general, LPS procedures lowers the risk of surgical site infections. (Kluytmans, 1997)
• Regarded as clean wound. • Entry into urinary tract clean contaminated
wound. prophylaxis with 1st gen. Cephalosporines. For 1-3 days.
• Using bowel neomycin + erythromycin or neomycin +metronidazole 18-24 hrs before op. and parental cefotetan or cefoxitin 30-60 min before incision.
Bacteria of preoperative urinary tract infections contaminate the surgical field and develop surgical
site infections in urological operations.• Hamsuna R, et al: Int J Urol 2004;11:941-7
• 134 major open urological operations. • Surgical wound swab cuture at the end of op: • AMP after op and lasting for 3 days.• 34 (25%) infectious complications.(SSI and UTI, etc)• Of 20 SSI (+), 15 (75%) had swab culture (+) and the b
acteria was sensitive to AMP in 20%.• Of 114 SSI (-), 14 (12%) had swab culture (+) and the b
acteria was sensitive to AMP in 86%.• Preop UTI was observed in 11 (55%) patients with SSI.
Of them 4 had same species in urine and wound. • Conclusions: preop UTI was the most important risk f
actor for SSI following urological op.
Discussion: Prophylactic Antibiotics in Open Nephrectomy
• 12% did not use preop. ABx. (Not complying to guidline)
• 58%-74% use postop ABx longer than 1 day. (Break the rule!)
• More use of Two kinds of antibiotics (preop. 13%, and postop.22%-29%) (Break the rule!)
• The rate of using antibiotics was less in LPS nephrectomy.
• But this is a clean op!! What are urologists afraid of? Invasiveness of the procedure and possible major adverse events after op.
Reliable Coverage of Antimicrobials
Antimicrobial or Antimicrobial ClassGram-Positive
PathogensGram-Negative Pathogens
Amoxicillin or ampicillinStreptococcus
EnterococciEscherichia coli
Proteus mirabilis
Amoxicillin with clavulanate Streptococcus E. coli
Ampicillin with sulbactamStaphylococcus (no
t MRSA)Enterococci
P. mirabilis Haemophilus influenzae, Klebsiella species
First-generation cephalosporins
Streptococcus Staphylococcus (not MRSA)
E. coli P. mirabilis Klebsiella species
Second-generation cephalosporins (cefamandole, cefuroxime, cefaclor)
Streptococcus Staphylococcus (not MRSA)
E. coli, P. mirabilis H. influenzae, Klebsiella species
Second-generation cephalosporins (cefoxitin, cefotetan)
StreptococcusE. coli, Proteus species (including indole +)
H. influenzae, Klebsiella species
Third-generation cephalosporins (ceftazidime, ceftriaxone)
Streptococcus Most, including P. aeruginosa
AminoglycosidesStaphylococcus
(urine)Most, including P. aeruginosa
Fluoroquinolones Streptococcus Most, including P. aeruginosa
Gap Between Regulations/ Guidelines and Practice on AMP for Herniorraphy
• Surgeons’ heavy duty? Safety for the patients or for the doctors? Empiric use of antibiotics to kill any pathogen that may enter through the open wound.
• Personal experience is not so good as the published reports and Severe mesh infection did occur. Are we afraid of legal problem?
• Selection of standard patients: Good results of Shouldice repair come from good selection of patients
Cephalosporin resistant urinary tract infections in young children
• Mehr SS, et al: J Paediatr Child Health 2004;40:48-52. (Melbourne, Australia)
• <6 y/o• 100 culture proved UTI.• E coli 90%. Proteus mirabilis 5%.• In vitro resistance to Ampicillin/amoxicilli
n: 52%, to TMP 14%, to cephalothin/cephalexin 24%.
• High resistance to TMP in Taiwan!!
Emergence of Reduced Sucsceptibility and Resistance to F-Quinolones in E Coli
• Taiwan had been ‘famous’ as one of the countries with highest resistant bacteria.
• In 1998, 1203 E coli isolates from 44 hospitals in Taiwan.
• 136 (11.3%) isolates were resistant to F-Q. and another 261 (21.7%) had reduced susceptibility.
• Acute and chronic quinolone use in cancer patients is a major selective pressure for resistance.
• McDonald LC, et al: Antimicrobial agents and chemotherapy 2001;45:3084-91.
Taiwan Surveillance On Antimicromial Resistance: Use of Antibiotics in Hospitals
• 6 medical centers + 8 regional hospitals• 663 adult inpatients in early 1999. • A total of 447 (67%) patients received
antibiotics for an overall rate of 813 antibiotic days per 1000 hospital days.
• Reasons to use antibiotics: 36% by experience, 29% by culture, and 30% for prophylaxis for SSI.
• Medical center was an independent predictor for increased use of antibiotics.
• McDonald LC, et al: Infection Control & Hospital Epidemiology 2001;22:565-71.
Taiwan Surveillance of Antimicromial Resistance in Taiwan: Bacteria
• 1st Cephalosporines were the most frequent (50%) prescribed antibiotics (Data from NHI).
• In 22 hospitals, The most common isolates were Enterobacteriaceae (E coli, K pneuomniae), S aureus, P aeruginosa. Accinobacter spp accounted for 10% isolates.
• MRSA accounts for 82% of hospital acquired infection, and . 40% of community acquired infection.
• Ho M, et al: J Microbio Immuno Infect 1999;32:239-49.
Guidelines for the use of prophylatctic antibiotics in Herniorraphy in Taiwan
J J Microbiol Immunol Infect 2004;37:71-4Microbiol Immunol Infect 2004;37:71-4
Site/procedure
Likely pathogens
Recommended antibiotics
Alternative Duration
Mesh +, open or LPS
S. aureus
CoNS
Cephazolin 1gm, IV at IA
Clindamycin 600mg IV at IA
1 dose
No mesh, open or LPS
S. aureus
CoNS
Nil or Cephazolin 1gm, IV at IA
Clindamycin 600mg IV at IA
1 dose
Prophylaxis for Herniorraphy RegulaProphylaxis for Herniorraphy Regulations: 0-1 dosetions: 0-1 dose
Lessons from clean wound surgery
Prophylactic Antibiotics for mesh ingunal hernioplasty: a meta-analysis
• Sanabria A, et al: Ann Surg 2007;245:392-6
• 6 RCT, 2507 eligible patients.• Antibiotic prophylaxis use in patients su
bmitted to mesh inguinal hernioplasty decreased the rate of SSI by almost 50%. (2.89% 1.38%)•Tzovaras G, et al: Int J ClinPract 2007;61:236-9: No effectiveness of prophylactic antibiotics for tension-free mesh hernia repair. (amoxicillin + clavoulani acid vs. placebo. 4.2% vs. 5.8%.
Terzi C, J Hosp Infect. 2006 Jan. meta-analysis: the value of prophylaxis on heriorraphy is inconclusive
SSI in Inguinal Herniorraphy, TCH, Taipei (2005-2006)
*All men had preoperative antibiotics, including 10 boys less than 18years. *54 (69.2%) cases used post op antibiotics. (Breaking regulations)*56 Mesh (+) cases. one (1.78%) had SSI.*22 Mesh (-) cases. None had SSI. *The only one SSI occurred in the mesh (+) patient who took post op antibiotics.*Conclusions: post op antibiotics is not necessary in herniorraphy.
Discussions: AMP for Hernia Repair
• Regulations and Guidelines: No antibiotics for repair without mesh. One dose for repair with mesh.
• Evidence: published reports on SSI rates after Inguinal hernia repair were around 2%, mostly skin infection.
• Mesh infection 0.9% in one report. (Jezupovs A, Mihelsons M: World J Surg 2006;30:2270-8)
• Our SSI rate after Mesh free repair was 0%, while that after mesh repair was 1.8%.
• Practice: 57% Taiwanese urologists followed the regulation. While 16% urologists used postoperative antibiotics for 3 days (much lower than 70% in 1990s) and 70% of cases in our hospital did not follow the regulations. (Better figures than that in 2000)